Hematology Analyzers & Reagents Market worth $15.59 billion by 2030, growing at a CAGR of 8.89% - Exclusive Report by 360iResearch

The "Hematology Analyzers & Reagents Market by Product & Service (Instrument, Regents, Services), Price Range (High-End Hematology Analyzers, Low-End Hematology Analyzers, Mid-Range Hematology Analyzers), End-User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Hematology Analyzers & Reagents Market to grow from USD 8.58 billion in 2023 to USD 15.59 billion by 2030, at a CAGR of 8.89%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/hematology-analyzers-reagents?utm_source=openpr&utm_medium=referral&utm_campaign=sample

In the medical field, hematology analyzers and reagents perform complete blood counts, coagulation tests, reticulocyte analyses, and white blood cell counts. For the most reliable patient outcomes, reagents and analyzer measuring technology, including the analysis algorithms, are precisely calibrated to one another. Numerous circulating blood cells, such as RBCs, WBCs, and platelets, can be counted and measured using modern hematology analyzers. Hematology analyzers use three primary physical technologies: electrical impedance, flow cytometry, and fluorescent flow cytometry. The growing number of blood disorders, strengthening of diagnostic laboratory chains, and recent advancements in genetics, stem cell research are driving the market growth. However, the associated safety concerns and multiple product recalls may hinder the market expansion activities. Nevertheless, the ongoing research and development activities for advanced hematology testing and the emergence of automated instruments may create a lucrative spectrum for the market.

The American region's hematology analyzer and reagents market is significantly evolving due to the rising incidence of blood disorders and the increasing number of cases of specific diseases. The American Red Cross reports that the United States requires about 29,000 units of red blood cells, 6,500 units of plasma, and 5,000 units of platelets each day. Moreover, the United States transfuses nearly 16 million blood components annually. As a result, the market for hematology analyzers and reagents has grown in importance due to the ongoing need for blood and its components for operations, cancer treatment, chronic illnesses, and traumatic accidents. The main domestic players present in the EMEA region are Siemens AG, ERBA Diagnostics Mannheim GmbH, PZ Cormay S.A., and EKF Diagnostics Holdings Plc. European market players are introducing automated hematology analyzers and reagents to lessen blood samples' possible health risks to laboratory employees. The need for efficient hematology analyzers and reagent requirements has increased due to the substantial prevalence of anemia in South Asian nations including India, Bangladesh, Bhutan, Pakistan, Sri Lanka, and Afghanistan. Additionally, the Asia-Pacific area has improved market prospects due to supportive government healthcare efforts, increased diagnostic laboratories, and the continued construction of healthcare infrastructure.

Market Segmentation & Coverage:

This research report categorizes the Hematology Analyzers & Reagents Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product & Service, market is studied across Instrument, Regents, and Services. The Instrument is further studied across 3 Part Hematology Analyzer, 5 Part Hematology Analyzer, and Point-of-care Testing Hematology Analyzer. The Services is further studied across Hematology Services, Hemostasis Services, and Immunohematology Services. The Instrument is projected to witness significant market share during forecast period.

Based on Price Range, market is studied across High-End Hematology Analyzers, Low-End Hematology Analyzers, and Mid-Range Hematology Analyzers. The Low-End Hematology Analyzers is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Government Reference Laboratories, Hospital Laboratories, and Research & Academic Institutes. The Research & Academic Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/hematology-analyzers-reagents?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Hematology Analyzers & Reagents Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Hematology Analyzers & Reagents Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Hematology Analyzers & Reagents Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., Beckman Coulter, Inc. by Danaher Corporation, BIOBASE Group, Bioevopeak Co., Ltd., Biogenix Inc. Pvt. Ltd., Biosystems S.A. by Ginper S.L., Boule Diagnostics AB, Cellavision AB, Chengdu Seamaty Technology Co., Ltd., CPC Diagnostics Pvt. Ltd., Diatron Medical Instruments Limited, Drucker Diagnostics, LLC, EDAN Instruments, Inc., EKF Diagnostics Holdings Plc, ERBA Diagnostics Mannheim GmbH, F. Hoffmann-La Roche Ltd., Genrui Biotech Co., Ltd., Getein Biotech, Inc., HORIBA, Ltd, Labnics Equipment Ltd., Labomed Inc., Linear Chemicals S.L.U., Medtronic PLC, Mindray Bio-Medical Electronics Co., Ltd., Nihon Kohden Corporation, Nova Biomedical Corporation, PZ Cormay S.A., Siemens AG, Sysmex Corporation, Thermo Fisher Scientific Inc., and Trivitron Healthcare.

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Hematology Analyzers & Reagents Market, by Product & Service
7. Hematology Analyzers & Reagents Market, by Price Range
8. Hematology Analyzers & Reagents Market, by End-User
9. Americas Hematology Analyzers & Reagents Market
10. Asia-Pacific Hematology Analyzers & Reagents Market
11. Europe, Middle East & Africa Hematology Analyzers & Reagents Market
12. Competitive Landscape
13. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Hematology Analyzers & Reagents Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Hematology Analyzers & Reagents Market?
3. What is the competitive strategic window for opportunities in the Hematology Analyzers & Reagents Market?
4. What are the technology trends and regulatory frameworks in the Hematology Analyzers & Reagents Market?
5. What is the market share of the leading vendors in the Hematology Analyzers & Reagents Market?
6. What modes and strategic moves are considered suitable for entering the Hematology Analyzers & Reagents Market?

Read More @ https://www.360iresearch.com/library/intelligence/hematology-analyzers-reagents?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.